Ozempic and Wegovy maker Novo Nordisk placed a print ad responding to the Super Bowl spot from competitor Hims & Hers.

Wegovy. Zepbound… and yes, Ozempic. A Kaiser Family Foundation poll found that one in 8 American adults reported trying a GLP-1 medication. “Body by Ozempic” has become a punchline on red ...

The trial revealed that Ozempic® 1 mg significantly lowered the relative risk of worsening kidney disease, kidney failure, and cardiovascular death by 24% compared to a placebo, in addition to ...

About 215,000 used GLP-1 drugs, while the rest were taking various other diabetes medications. Though semaglutides like Ozempic and Wegovy dominate the market in the U.S., Al-Aly and his team ...

Ozempic is also not approved for use in people who have type 1 diabetes. Read on to learn more about the effect that people call “Ozempic neck.” GLP-1 receptor agonists (GLP-1 RAs) are a group ...

These and other GLP1-RA diabetes/weight-loss meds can also boost outcomes for folks battling chronic kidney disease, new ...

Looking for a natural alternative to GLP-1 drugs? Integrative medicine physician Dr. Taz Bhatia has shared three foods that ...

GLP-1 is amongst a number of hormones that regulate fullness ... Q: What’s one less-known misconception about Ozempic and the other drugs above? A: The most common misconception is that people think ...

Reports link GLP-1 medications like Ozempic and Mounjaro to vision loss, prompting concerns over their safety.

The popular weight-loss drugs known as GLP-1 receptor agonists, which were originally meant to treat diabetes, surged in ...